How Genomic Prostate Score (GPS) Works
Assessing your treatment choices once you have been diagnosed with localized prostate Cancer.
Just as every patient is different, so is every prostate cancer tumor. The GPS test uses genomics to give you and your doctor important risk information about how your individual tumor will likely behave. Valuable insights include:
- How aggressive your cancer is
- How likely you are to die from your cancer within 10 years of surgery
- How likely your cancer is to spread to other parts of your body (metastasis) within 10 years of surgery
Your GPS result can help you and your doctor determine what type of treatment is right
for you based on your tumor’s characteristics.
You may be a candidate for the GPS test if you have:
✔ Biopsy within 3 years
✔ Not started treatment
✔ Localized prostate cancer*
The Genomic Prostate Score (GPS) test is performed on a small tissue sample that’s already been taken from your most recent biopsy. Once the sample has arrived at the mdxhealth lab*, the GPS test measures the activity of the group of cancer-related
genes that are in your tumor tissue. The activity of these genes can provide important information about how your specific cancer might behave in the future, including:
- Your level of risk for prostate cancer death
- How likely your cancer is to metastasize with 10 years after surgery
- Your risk for adverse pathology
